Calcium channel linked to cancer drug resistance
Chemotherapy tumor resistance develops after long-term regimens of the platinum-containing anticancer drug carboplatin. Scientists have observed an enlarged cell morphology and involvement of T-type calcium channels in resistant ovarian cancer cells. Sooyun Kim and researchers at Seoul National University wanted to find out if these characteristics also relate to carboplatin resistance seen in retinoblastoma, an aggressive childhood cancer. They published their findings in a recent Journal of Biological Chemistry article.

Immunofluorescence staining and pharmacological inhibition experiments identified the Cav3.3 channel as the overexpressed calcium channel subtype that contributes to the sustained currents. The authors further showed that messenger RNA expression levels only for Cav3.3 increased after carboplatin exposure, while the levels for the other Cav3.1 and Cav3.2 subtypes slightly decreased in the resistant cells relative to the original retinoblastoma strain.
Finally, the researchers determined that treating the resistant retinoblastoma giant cells with a Cav3.3 inhibitor increased their sensitivity to carboplatin. They only observed this increase in carboplatin sensitivity in the resistant cells and not in the original retinoblastoma strain, indicating that Cav3.3 plays a specific role in drug resistance.
Cav3.3 could potentially be a target for the treatment of carboplatin-resistant retinoblastoma. Future experiments will help identify additional proteins and pathways that may connect Cav3.3 to chemotherapeutic resistance in retinoblastoma and whether the involvement of Cav3.3 over the other channel subtypes is observed in other cancers.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Zebrafish model links low omega-3s to eye abnormalities
Researchers at the University of Colorado Anschutz developed a zebrafish model to show that low maternal docosahexaenoic acid can disrupt embryo eye development and immune gene expression, offering a tool to study nutrition in neurodevelopment.

Top reviewers at ASBMB journals
Editors recognize the heavy-lifters and rising stars during Peer Review Week.

Teaching AI to listen
A computational medicine graduate student reflects on building natural language processing tools that extract meaning from messy clinical notes — transforming how we identify genetic risk while redefining what it means to listen in science.

Early lipid changes drive retinal degeneration in Zellweger spectrum disorder
Lipid profiling in a rare disease mouse model reveals metabolic shifts and inflammation in the retinal pigment epithelium — offering promising biomarker leads to combat blindness.

How sugars shape Marfan syndrome
Research from the University of Georgia shows that Marfan syndrome–associated fibrillin-1 mutations disrupt O glycosylation, revealing unexpected changes that may alter the protein's function in the extracellular matrix.

What’s in a diagnosis?
When Jessica Foglio’s son Ben was first diagnosed with cerebral palsy, the label didn’t feel right. Whole exome sequencing revealed a rare disorder called Salla disease. Now Jessica is building community and driving research for answers.